These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 39007962)

  • 1. Immunogenicity of mesenchymal stromal/stem cells.
    Chen W; Lv L; Chen N; Cui E
    Scand J Immunol; 2023 Jun; 97(6):e13267. PubMed ID: 39007962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications.
    Lee DK; Song SU
    Cell Immunol; 2018 Apr; 326():68-76. PubMed ID: 28919171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal Stem Cells Derived from Human Urine-Derived iPSCs Exhibit Low Immunogenicity and Reduced Immunomodulatory Profile.
    Wang P; Zhang Y; Li Z; Zhou S; Tang Q; Wang Z; Xiao R; Feng M; Wu L; Liang D
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation effect of mesenchymal stem cells in islet transplantation.
    Shrestha M; Nguyen TT; Park J; Choi JU; Yook S; Jeong JH
    Biomed Pharmacother; 2021 Oct; 142():112042. PubMed ID: 34403963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
    Yi T; Song SU
    Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research Status of Mesenchymal Stem Cells in Liver Transplantation.
    You Y; Wen DG; Gong JP; Liu ZJ
    Cell Transplant; 2019 Dec; 28(12):1490-1506. PubMed ID: 31512503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Immunological Considerations.
    Refaie AF; Elbassiouny BL; Kloc M; Sabek OM; Khater SM; Ismail AM; Mohamed RH; Ghoneim MA
    Front Immunol; 2021; 12():690623. PubMed ID: 34248981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cell-mediated immunomodulation in cell therapy of neurodegenerative diseases.
    Chen X; Wang S; Cao W
    Cell Immunol; 2018 Apr; 326():8-14. PubMed ID: 28778534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.
    Markov A; Thangavelu L; Aravindhan S; Zekiy AO; Jarahian M; Chartrand MS; Pathak Y; Marofi F; Shamlou S; Hassanzadeh A
    Stem Cell Res Ther; 2021 Mar; 12(1):192. PubMed ID: 33736695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions.
    Wang J; Liao L; Tan J
    Expert Opin Biol Ther; 2011 Jul; 11(7):893-909. PubMed ID: 21449634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role for mesenchymal stem cells in autoimmune diseases?
    Uccelli A; Mancardi G; Chiesa S
    Autoimmunity; 2008 Dec; 41(8):592-5. PubMed ID: 18958745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities.
    Moradinasab S; Pourbagheri-Sigaroodi A; Zafari P; Ghaffari SH; Bashash D
    Int Immunopharmacol; 2021 Aug; 97():107694. PubMed ID: 33932694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
    Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
    Front Immunol; 2020; 11():54. PubMed ID: 32117234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications.
    Huang Y; Wu Q; Tam PKH
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the Immunological Mechanisms of Mesenchymal Stem Cells in Allogeneic Transplantation: From the Aspect of Major Histocompatibility Complex Class I.
    Wang Y; Tian M; Wang F; Heng BC; Zhou J; Cai Z; Liu H
    Stem Cells Dev; 2019 Sep; 28(17):1141-1150. PubMed ID: 31215341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effects of mesenchymal stem cells for the treatment of cardiac allograft rejection.
    Wu Z; Liang J; Huang W; Jiang L; Paul C; Gao X; Alam P; Kanisicak O; Xu M; Wang Y
    Exp Biol Med (Maywood); 2021 Apr; 246(7):851-860. PubMed ID: 33327780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells derived from human dental follicle modulate the aberrant immune response in atopic dermatitis.
    Zibandeh N; Genc D; Ozgen Z; Duran Y; Goker K; Baris S; Ergun T; Akkoc T
    Immunotherapy; 2021 Jul; 13(10):825-840. PubMed ID: 33955241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Latest Developments in Immunomodulation of Mesenchymal Stem Cells in the Treatment of Intrauterine Adhesions, Both Allogeneic and Autologous.
    Chen JM; Huang QY; Zhao YX; Chen WH; Lin S; Shi QY
    Front Immunol; 2021; 12():785717. PubMed ID: 34868069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulative effects of mesenchymal stem cells derived from human embryonic stem cells in vivo and in vitro.
    Tan Z; Su ZY; Wu RR; Gu B; Liu YK; Zhao XL; Zhang M
    J Zhejiang Univ Sci B; 2011 Jan; 12(1):18-27. PubMed ID: 21194182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.